user

Long-term Survival and Toxicity of Patients Treated With Ultra-high-dose IMRT for Localized Prostate Cancer

被引：0
|
作者：
Spratt, D. [1 ]
Pei, X. [1 ]
Yamada, J. [1 ]
Kollmeier, M. A. [1 ]
Cox, B. [1 ]
Zhang, Z. [1 ]
Zelefsky, M. J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Long-term Survival and Toxicity in Patients Treated With High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer
    Spratt, Daniel E.
    Pei, Xin
    Yamada, Josh
    Kollmeier, Marisa A.
    Cox, Brett
    Zelefsky, Michael J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (03): : 686 - 692
  • [2] Predictors of long-term survival for localized prostate cancer treated with high-dose IMRT stratified by NCCN 2015 guidelines in a community hospital setting
    Ricco, Anthony
    Lanciano, Rachelle
    Hanlon, Alexandra
    JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (01) : 95 - 101
  • [3] Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
    Deutsch, Israel
    Zelefsky, Michael J.
    Zhang, Zhigang
    Mo, Qianxing
    Zaider, Marco
    Cohen, Gil'ad
    Cahlon, Oren
    Yamada, Yoshiya
    BRACHYTHERAPY, 2010, 9 (04) : 313 - 318
  • [4] Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes
    Cahlon, Oren
    Zelefsky, Michael J.
    Shippy, Alison
    Chan, Heather
    Fuks, Zvi
    Yamada, Yoshiya
    Hunt, Margie
    Greenstein, Steven
    Amols, Howard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02): : 330 - 337
  • [5] Escalated-dose IMRT for prostate cancer: long-term toxicity and biochemical outcomes
    Bettina, H.
    Strauss, D.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S349 - S349
  • [6] Long-term toxicity outcomes after high dose conformal radiotherapy for clinically localized prostate cancer
    Shippy, A. M.
    Hunt, M. A.
    Yamada, Y.
    Chan, H. M.
    Greenstein, S.
    Amols, H. I.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S33 - S34
  • [7] Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy
    Kawamura, Norihiko
    Hayashi, Takuji
    Nagahara, Akira
    Nakai, Yasutomo
    Nakayama, Masashi
    Ikawa, Toshiki
    Kanayama, Naoyuki
    Morimoto, Masahiro
    Konishi, Koji
    Nishimura, Kazuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (03) : 346 - 351
  • [8] Late Toxicity and Outcomes in High-risk Prostate Cancer Patients Treated With Hypofractionated IMRT and Long-term Androgen Suppression Treatment
    Pervez, Nadeem
    Boychak, Alex
    Drodge, Claudia S.
    Yee, Don
    Le, Duc
    Murtha, Albert
    Parliament, Matthew
    Amanie, John
    Mihai, Alina
    Field, Colin
    Mackenzie, Marc
    Ghosh, Sunita
    Fallone, Gino
    Pearcey, Robert
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (02): : 200 - 206
  • [9] LONG-TERM SURVIVAL AMONG MEN WITH CONSERVATIVELY TREATED LOCALIZED PROSTATE-CANCER
    ALBERTSEN, PC
    FRYBACK, DG
    STORER, BE
    KOLON, TF
    FINE, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (08): : 626 - 631
  • [10] Long-term outcomes in patients treated with proton therapy for localized prostate cancer
    Takagi, Masaru
    Demizu, Yusuke
    Terashima, Kazuki
    Fujii, Osamu
    Jin, Dongcun
    Niwa, Yasue
    Daimon, Takashi
    Murakami, Masao
    Fuwa, Nobukazu
    Okimoto, Tomoaki
    CANCER MEDICINE, 2017, 6 (10): : 2234 - 2243
12345